Finally, tissue cholesterol homeostasis in mouse models of obesity and T2DM was restored in response to VEGF‐B targeting, highlighting the possible impact of membrane cholesterol content on multiple signaling and transport systems involved in disease progression, and the involvement of VEGF‐B signaling for its regulation. Here, VEGFB is linked to obesity disorder.